<?xml version="1.0"?>
<rss version="2.0" xmlns:blogChannel="http://backend.userland.com/blogChannelModule">
	<channel>
		<title>Medscape Today Headlines</title>
		<link>http://www.medscape.com/medscapetoday?src=rss</link>
		<description>Latest medical news, articles, and features from Medscape Today</description>
		<image>
			<url>http://images.medscape.com/pi/global/logos/mscp/logo-medscape110x30.gif</url>
			<title>Medscape Today Headlines</title>
			<link>http://www.medscape.com/medscapetoday?src=rss</link>
		</image>
		<language>en-us</language>
		<copyright>Copyright 2008, Medscape</copyright>
		<pubDate>Fri, 9 May 2008 16:04:19 EDT</pubDate>
		<managingEditor>MedscapeTodayEditor@medscape.net</managingEditor>
		<webMaster>medscapecustomersupport@webmd.net (Medscape Customer Support)</webMaster>

		<item>
			<title>Discrepancies in US/European Guidelines on Antithrombotics for ACS</title>
			<link>http://www.medscape.com/viewarticle/574287?src=rss</link>
			<description>Discrepancies in the European and US guidelines on recommendations for the use of enoxaparin and fondaparinux in the treatment of ACS is causing confusion, some clinicians have suggested.  &lt;br /&gt; &lt;i&gt;Heartwire&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Fri, 9 May 2008 14:14:00 EDT</pubDate>
		</item>
		<item>
			<title>WAFACS Published: No CVD Benefit in Longest-Duration Folic-Acid/B-Vitamin Supplementation Study</title>
			<link>http://www.medscape.com/viewarticle/574263?src=rss</link>
			<description>A study on folic-acid and B-vitamin supplementation demonstrates homocysteine lowering as a useful marker in the prediction of cardiovascular disease but has no effect on cardiovascular outcomes.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Fri, 9 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Hormone Therapy Linked to Stroke Risk Regardless of Timing of Treatment Initiation</title>
			<link>http://www.medscape.com/viewarticle/574261?src=rss</link>
			<description>New analysis of data from the Nurses&apos; Health Study shows an increased stroke risk associated with both estrogen alone and estrogen plus progestin, regardless of treatment or timing of initiation.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Neurology &amp; Neurosurgery</category>
					<pubDate>Fri, 9 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Decreased Respiratory Function in Infants Linked to Antenatal Steroid Therapy</title>
			<link>http://www.medscape.com/viewarticle/574262?src=rss</link>
			<description>In a prospective cohort study, infants who were 25 to 32 weeks&apos; gestation and remotely treated with antenatal steroids at a mean of 21 days before delivery had lower cardiorespiratory function.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Pediatrics</category>
					<pubDate>Fri, 9 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Eosinopenia Reliably Identifies Sepsis in Critically Ill Patients</title>
			<link>http://www.medscape.com/viewarticle/574260?src=rss</link>
			<description>Eosinopenia is better than C-reactive protein at indicating sepsis in patients in intensive care units.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Critical Care</category>
					<pubDate>Fri, 9 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Cost -- Not Evidence -- Driving Shift in Cancer Screening</title>
			<link>http://www.medscape.com/viewarticle/574242?src=rss</link>
			<description>High-deductible health plans could be prompting patients to choose fully covered screening tests to avoid out-of-pocket expenses.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Thu, 8 May 2008 16:43:00 EDT</pubDate>
		</item>
		<item>
			<title>Vascular Benefits of Stopping Smoking Are Rapid</title>
			<link>http://www.medscape.com/viewarticle/574191?src=rss</link>
			<description>Women who quit smoking will see a rapid decline in the risk for death from coronary heart disease and other vascular disorders, a new analysis of the Nurses&apos; Health Study shows.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Thu, 8 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Inflammatory Markers Predict Congestive Heart Failure</title>
			<link>http://www.medscape.com/viewarticle/574192?src=rss</link>
			<description>The inflammatory markers IL-6, C-reactive protein, and macroalbuminuria suggest a mechanistic link between obesity and congestive heart failure, researchers say.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Thu, 8 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>New Monoclonal Antibody Effective for RSV Prophylaxis in High-Risk, Full-Term Infants</title>
			<link>http://www.medscape.com/viewarticle/574193?src=rss</link>
			<description>The monoclonal antibody motavizumab reduces the risk for respiratory syncytial virus illness and hospitalization in high-risk, full-term American Indian infants.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Pediatrics</category>
					<pubDate>Thu, 8 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Long-Term Use of Ibuprofen Lowers Alzheimer&apos;s Disease Risk</title>
			<link>http://www.medscape.com/viewarticle/574190?src=rss</link>
			<description>Long-term use of nonsteroidal anti-inflammatory drugs, specifically ibuprofen, lowers the risk for Alzheimer&apos;s disease.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Neurology &amp; Neurosurgery</category>
					<pubDate>Thu, 8 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>American Academy of Pediatrics Updates Review of Soy Protein-Based Formulas</title>
			<link>http://www.medscape.com/viewarticle/574189?src=rss</link>
			<description>The American Academy of Pediatrics has updated its 1998 review of soy protein-based formulas and addresses the advantages and disadvantages of phytoestrogens in soy formulas.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Pediatrics</category>
					<pubDate>Thu, 8 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>FDA Approvals: Advair, Relistor, Aplenzin</title>
			<link>http://www.medscape.com/viewarticle/574187?src=rss</link>
			<description>The FDA has approved an expanded indication for fluticasone propionate/salmeterol inhalation powder, methylnaltrexone bromide subcutaneous injection, and bupropion HBr extended-release tablets.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Pharmacist</category>
					<pubDate>Thu, 8 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Highlights of the American Academy of Allergy, Asthma &amp; Immunology 2008 Annual Meeting</title>
			<link>http://www.medscape.com/viewprogram/12590?src=rss</link>
			<description>Read clinically focused news coverage of key developments on exercise-induced asthma, new research initiatives in asthma, and more from AAAAI 2008.  &lt;br /&gt; &lt;i&gt;Medscape Allergy &amp; Clinical Immunology&lt;/i&gt;</description>
			<category>Allergy/Clinical Immunology</category>
					<pubDate>Thu, 8 May 2008 12:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Both Researchers and Journals are to Blame for Inconsistent Disclosure of Conflicts of Interest</title>
			<link>http://www.medscape.com/viewarticle/574123?src=rss</link>
			<description>Researchers who combed through one year&apos;s worth of stent research say conflict-of-interest disclosures are the exception, not the rule--in some cases, authors disclosed conflicts in one paper, but not others. Inconsistent journal policies and confusion about what constitutes a &quot;relevant&quot; conflict may explain some--but not all--of the gaps.   &lt;br /&gt; &lt;i&gt;Heartwire&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Wed, 7 May 2008 09:12:00 EDT</pubDate>
		</item>
		<item>
			<title>Maternal Hyperglycemia Linked to Adverse Pregnancy Outcomes</title>
			<link>http://www.medscape.com/viewarticle/574125?src=rss</link>
			<description>A study shows that maternal glucose levels below the range indicating diabetes are linked with increased birth weight and increased cord-blood serum C-peptide levels in infants.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Ob/Gyn and Women&apos;s Health</category>
					<pubDate>Wed, 7 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Metformin Alone or With Insulin May Be Safe in Gestational Diabetes</title>
			<link>http://www.medscape.com/viewarticle/574129?src=rss</link>
			<description>In pregnant women with gestational diabetes, metformin alone or supplemented with insulin did not increase neonatal hypoglycemia or other perinatal complications vs insulin alone.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Ob/Gyn and Women&apos;s Health</category>
					<pubDate>Wed, 7 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Urinary Incontinence More Common in Elderly Women Taking Certain Medications</title>
			<link>http://www.medscape.com/viewarticle/574132?src=rss</link>
			<description>Use of estrogen or alpha-blockers increases the occurrence of self-reported urinary incontinence.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Internal Medicine</category>
					<pubDate>Wed, 7 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>FDA Safety Changes: Janumet, WelChol, Rituxan</title>
			<link>http://www.medscape.com/viewarticle/574124?src=rss</link>
			<description>The FDA has approved revisions to the safety labeling for sitagliptin plus metformin HCl tablets (Janumet), colesevelam HCl tablets (WelChol), and rituximab intravenous injection (Rituxan).  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Pharmacist</category>
					<pubDate>Wed, 7 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Breast Cancer Within 2 Years of Childbirth Linked to Poor Prognosis</title>
			<link>http://www.medscape.com/viewarticle/574130?src=rss</link>
			<description>A study shows that women who have breast cancer within 2 years of their last pregnancy (or 2-4 years) after delivery are more likely to have a poor prognosis.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Ob/Gyn and Women&apos;s Health</category>
					<pubDate>Wed, 7 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Eszopiclone Plus Escitalopram May Rapidly Improve Insomnia, Anxiety</title>
			<link>http://www.medscape.com/viewarticle/574131?src=rss</link>
			<description>A randomized controlled trial shows that coadministration of eszopiclone and escitalopram rapidly improves sleep and anxiety in patients with insomnia and generalized anxiety disorder.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Internal Medicine</category>
					<pubDate>Wed, 7 May 2008 17:00:00 EDT</pubDate>
		</item>

</channel>
</rss>